GenomeDx Biosciences
GenomeDx develops and commercializes genomic tests for urologic cancers. Its proprietary Decipher GRID platform is a clinically annotated genomic expression database, and its flagship product predicts the probability of prostate cancer metastasis after surgery by measuring expression levels of 22 biomarkers. Founded in 2008 in San Diego, United States, the company has raised $69.7M in Series C funding from investors…
Funding snapshot
About
GenomeDx develops and commercializes genomic tests for urologic cancers. Its proprietary Decipher GRID platform is a clinically annotated genomic expression database, and its flagship product predicts the probability of prostate cancer metastasis after surgery by measuring expression levels of 22 biomarkers. Founded in 2008 in San Diego, United States, the company has raised $69.7M in Series C funding from investors including Merck Global Health Innovation Fund and Baird Capital. Founded in 2008, headquartered in San Diego, United States. The team comprises 159 (Dec 31, 2. The company operates in Life Sciences > Genomics, Life Sciences > Oncology, Life Sciences > Clinical Genomics, Life Scien.
Business model
Oncology > In-Vitro Diagnostic Tests > Prostate Cancer,
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Hybridization-based > Microarrays,
Life Sciences Platforms and Tools > Research Assays > Drug Discovery > Microarrays
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like GenomeDx Biosciences?
Analyze your pitch deck before your next raise.
Analyze My Deck →